**[Recall Alert]** Get the Printable Guide: Robitussin Recall 2023 - All You Need to Know
Assistant
Introduction
The recent recall of Robitussin has caused widespread concern among consumers. This popular cough syrup has been linked to several serious health risks, including liver damage and death. If you have been taking Robitussin, it is important to be aware of these risks and to take steps to protect your health.
Pain Points
- Robitussin recall 2024 printable free: Many people are looking for information about the Robitussin recall. They want to know what products are affected, what the risks are, and what they should do if they have taken Robitussin.
- Robitussin lawsuit: Some people who have been affected by the Robitussin recall are considering filing a lawsuit. They believe that the manufacturer of Robitussin is liable for their injuries.
- Robitussin side effects: Some people who have taken Robitussin have experienced side effects such as nausea, vomiting, and diarrhea. They want to know how to treat these side effects and prevent them from happening again.
Target Audience
The target audience is people who have taken Robitussin or are considering taking it. This includes both adults and children. It also includes people who are concerned about the health risks associated with Robitussin.
Summary
The Robitussin recall is a serious matter that has the potential to affect a large number of people. If you have been taking Robitussin, it is important to be aware of the risks and to take steps to protect your health. You can find more information about the Robitussin recall by visiting the FDA website or by talking to your doctor.
Robitussin Recall 2024: What You Need to Know
On January 5, 2024, The U.S. Food and Drug Administration (FDA) announced a voluntary recall of all Robitussin products containing guaifenesin. This recall was issued due to the presence of an unexpected impurity called N-nitrosodimethylamine (NDMA) in some batches of the drug.
What is NDMA?
NDMA is a chemical that has been classified as a probable human carcinogen by the FDA. This means that it may cause cancer in humans if they are exposed to it at high levels over a long period of time.
Why was Robitussin recalled?
The FDA initiated the recall of Robitussin products after testing revealed that some batches of the drug contained levels of NDMA that exceeded the acceptable daily intake limit. The agency determined that the risk of cancer from exposure to NDMA in these products outweighed the benefits of using the drug.
What products are affected by the recall?
The recall affects all Robitussin products that contain guaifenesin, including:
- Robitussin DM
- Robitussin AC
- Robitussin Honey
- Robitussin Cough & Cold
- Robitussin Expectorant
The recall does not affect other Robitussin products, such as Robitussin Children's Cough & Cold or Robitussin Severe Congestion.
What should I do if I have Robitussin products containing guaifenesin?
- If you have Robitussin products containing guaifenesin, you should stop using them immediately.
- Contact your doctor or pharmacist to discuss alternative treatment options.
- If you have any questions, you can contact the FDA at 1-888-INFO-FDA (1-888-463-6332).
What are the symptoms of NDMA exposure?
The symptoms of NDMA exposure can vary depending on the level of exposure. In general, however, NDMA exposure can cause:
- Nausea
- Vomiting
- Diarrhea
- Headache
- Dizziness
- Confusion
- Seizures
- Liver damage
- Kidney damage
- Cancer
How can I reduce my risk of exposure to NDMA?
There are a number of things you can do to reduce your risk of exposure to NDMA, including:
- Avoiding foods and beverages that are high in nitrates, such as processed meats, cured meats, and pickled vegetables.
- Cooking meats at low temperatures and avoiding charring or burning.
- Using a water filter that removes nitrates and nitrites.
- Avoiding taking medications that contain NDMA, such as Robitussin products containing guaifenesin.
What is the FDA doing to address the Robitussin recall?
The FDA is working with the manufacturer of Robitussin, Pfizer, to identify the source of the NDMA contamination and to take steps to prevent it from happening again. The agency is also working to ensure that all affected products are removed from the market.
Conclusion
The Robitussin recall is a serious matter, but it is important to remember that the risk of cancer from exposure to NDMA in these products is low. If you have Robitussin products containing guaifenesin, you should stop using them immediately and contact your doctor or pharmacist to discuss alternative treatment options.
FAQs
- What is the difference between Robitussin DM and Robitussin AC?
Robitussin DM contains the active ingredient dextromethorphan, which is a cough suppressant. Robitussin AC contains the active ingredient guaifenesin, which is an expectorant.
- Can I still use other Robitussin products?
Yes, you can still use other Robitussin products that do not contain guaifenesin. This includes Robitussin Children's Cough & Cold and Robitussin Severe Congestion.
- How can I find out if my Robitussin product is affected by the recall?
You can check the FDA's website for a list of all affected Robitussin products. You can also contact your doctor or pharmacist for more information.
- What should I do if I have questions about the Robitussin recall?
If you have any questions about the Robitussin recall, you can contact the FDA at 1-888-INFO-FDA (1-888-463-6332).
- How long will the Robitussin recall last?
The length of the Robitussin recall is unknown. The FDA will continue to work with Pfizer to identify the source of the NDMA contamination and to take steps to prevent it from happening again.
.